Andrew Craig Miller, Chief Operating Officer at Karuna Therapeutics, Inc. (KRTX), sold 45,000 shares at $200.16 ($9.0M) on 2023-04-18, disclosed to the SEC on 2023-04-20.
Scheduled sale ($9.0M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.16 | 30,000 | $6.0M | 66.7% |
| 2 | $200.13 | 15,000 | $3.0M | 33.3% |
| Total | $200.15 avg | 45,000 | $9.0M | 100% |
| Filing → |
| KRTX | SELL | 2022-11-03 | $3.4M | — | Filing → |
| KRTX | SELL | 2021-11-03 | $620K | — | Filing → |
| KRTX | SELL | 2021-10-05 | $3.9M | — | Filing → |